BRÈVE

sur AMOEBA (EPA:ALMIB)

Amoéba Secures First Order from Koppert, Marks Commercial Transition

Graphique de l'évolution du cours de l'action AMOEBA (EPA:ALMIB).

Chassieu (France), 11 March 2026 - Amoéba, a greentech company specializing in microbiological solutions using amoebae, has received its first order from its partner Koppert, a leader in biocontrol. This order reflects Amoéba's shift to a commercial entity, focusing on biocontrol activities through its subsidiary, Green 4 Agro.

The order follows a distribution agreement signed in June 2025, covering vineyards and market gardens across 18 European countries and the U.S. Deliveries will begin in April 2026. This milestone will help Amoéba meet demand in France, Italy, and the Netherlands, amid evolving regulatory conditions.

Amoéba's collaboration with Koppert shows promise, continuing from the launch of TIAGAN, a solution for vineyards. Under the leadership of Jean-Marc PETAT, Green 4 Agro is set to expand its biofungicide offerings, emphasizing environmentally friendly solutions for agricultural professionals.

R. E.

Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.

Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève

Voir toutes les actualités de AMOEBA